Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Carroll

Showing results (911-920 of 963) with videos related to

Pageof 97
Sort By:
Diabetes|September 6, 2015
Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic RetinopathyJudd M Cahoon, Ruju R Rai, Lara S Carroll, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Cell Metabolism|June 13, 2025
The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injuryJesse S S Novak, Lisa Polak, Sanjeethan C Baksh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate CancerEmanuela Dylgjeri, Vishal Kothari, Ayesha A Shafi, et al.
Nature|June 8, 2022
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancerSaroor A Patel, Shoko Hirosue, Paulo Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Elife|February 1, 2017
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in miceJeroen Overman, Frank Fontaine, Mehdi Moustaqil, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Pageof 97

Showing results (911-920 of 963) with videos related to

Sort By:
Pageof 97
Diabetes|September 6, 2015
Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic RetinopathyJudd M Cahoon, Ruju R Rai, Lara S Carroll, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
Cell Metabolism|June 13, 2025
The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injuryJesse S S Novak, Lisa Polak, Sanjeethan C Baksh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate CancerEmanuela Dylgjeri, Vishal Kothari, Ayesha A Shafi, et al.
Nature|June 8, 2022
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancerSaroor A Patel, Shoko Hirosue, Paulo Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Elife|February 1, 2017
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in miceJeroen Overman, Frank Fontaine, Mehdi Moustaqil, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Pageof 97